Coagulation Analyzer

WhatsApp Order

A Coagulation Analyzer is a compact, automated instrument designed for performing essential tests that evaluate the blood’s clotting ability. It accurately measures key parameters such as Prothrombin Time (PT/INR), Activated Partial Thromboplastin Time (aPTT), Thrombin Time, and Fibrinogen, which are critical for monitoring anticoagulant therapy (warfarin, heparin), diagnosing bleeding disorders, and assessing surgical risk. With its photometric detection and user-friendly operation, it delivers reliable results for small to medium-volume laboratories, clinics, and hospital wards. Its role in ensuring safe and effective patient management in thrombosis and hemostasis makes it a vital tool in clinical diagnostics.

Categories: LABORATORY EQUIPMENT AND SUPPLIES, Analyzers Tags: aPTT, BloodCoagulation, CoagulationAnalyzer, DiagnosticLab, HematologyAnalyzer, PTINR

Description

Coagulation Analyzer

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Monitoring Anticoagulant Therapy:

Primary Use: The primary and most critical use is to monitor patients on blood-thinning medications. It measures the International Normalized Ratio (INR) for patients on warfarin (Coumadin) and activated partial thromboplastin time (aPTT) for patients on unfractionated heparin, ensuring therapeutic efficacy and preventing bleeding or clotting complications.
How it helps: Acts as a safety guardian for patients on blood thinners, giving doctors the precise information they need to adjust doses so the medication is strong enough to prevent dangerous clots but not so strong that it causes life-threatening bleeding.

2. Diagnosis of Bleeding & Thrombotic Disorders:

Primary Use: Essential for evaluating patients with unexplained bleeding, bruising, or a history of thrombosis. It helps diagnose coagulation factor deficiencies (e.g., Hemophilia A/B via aPTT), vitamin K deficiency, liver disease, and disseminated intravascular coagulation (DIC).
How it helps: Provides answers for patients suffering from mysterious bleeding or clotting episodes, identifying the root cause so they can receive targeted treatment and understand why their body is not clotting normally.

3. Pre-operative Coagulation Screening:

Primary Use: Routinely performed before surgeries (especially major or invasive procedures) to identify patients with unsuspected coagulopathies (e.g., prolonged PT/aPTT) that could lead to excessive surgical bleeding.
How it helps: Prevents surgical disasters by catching hidden bleeding risks before the first incision, allowing the surgical team to take precautions and ensuring patients can undergo procedures safely.

4. Assessment of Liver Function:

Primary Use: The Prothrombin Time (PT) is a sensitive marker of the liver’s synthetic function, as the liver produces most coagulation factors. A prolonged PT can indicate significant liver damage or disease.
How it helps: Provides doctors with a crucial window into liver health, helping them detect liver damage early and monitor disease progression in patients with hepatitis, cirrhosis, or other liver conditions.

5. Evaluation of Coagulation Factor Activity:

Primary Use: Used to perform specific factor assays (e.g., Factor VIII, IX) to quantify the level of a deficient factor, which is critical for diagnosing and managing inherited bleeding disorders.
How it helps: Gives patients with hemophilia and their doctors precise information about which clotting factor is deficient and by how much, enabling targeted replacement therapy that can prevent bleeding episodes and joint damage.

SECONDARY & SUPPORTIVE USES

1. Monitoring During Massive Transfusion: Used to guide transfusion therapy (with Fresh Frozen Plasma, Cryoprecipitate) in trauma, cardiac surgery, or other major hemorrhages by assessing the coagulation status in real-time, helping medical teams give patients exactly what they need to stop bleeding.

2. Detection of Lupus Anticoagulants & Antiphospholipid Syndrome: Performs specialized tests like the dilute Russell’s viper venom time (dRVVT) and lupus-sensitive aPTT as part of the diagnostic workup, helping identify an autoimmune condition that causes dangerous blood clots.

3. Point-of-Care Testing (POCT): In critical care units (ICU, Cardiac Cath Lab) or operating rooms, coagulation analyzers provide rapid results to guide immediate clinical decisions, ensuring critically ill patients receive timely interventions.

4. Research & Drug Development: Used in clinical trials for new anticoagulant and procoagulant drugs, helping researchers develop safer, more effective medications for patients with clotting disorders.

KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

Device Type: Automated, Benchtop Coagulation Analyzer.
Methodology: Typically uses photometric (optical density) detection to measure clot formation. Some models may also use mechanical (ball or viscosity) detection.
Test Principle: Measures the time it takes for a plasma sample to clot after the addition of specific reagents (e.g., thromboplastin for PT, activator/phospholipids for aPTT).

2. TECHNICAL & PERFORMANCE PROPERTIES

Core Tests Performed:
- Prothrombin Time (PT) / International Normalized Ratio (INR)
- Activated Partial Thromboplastin Time (aPTT)
- Thrombin Time (TT)
- Fibrinogen (Clauss Method)
- D-Dimer (on some models)
Throughput & Channels: Designed for small to medium workload (e.g., 1-4 independent channels), allowing for simultaneous or sequential testing of different parameters on a single sample. Typical throughput of 50-100 tests per hour.
Sample Type: Uses citrated plasma (blood collected in 3.2% sodium citrate tubes, centrifuged to obtain platelet-poor plasma). Capable of testing single samples or small batches.
Calibration & ISI: Requires calibration with International Sensitivity Index (ISI)-specific calibrators for PT/INR to ensure standardized, reproducible results across instruments and laboratories.
Quality Control (QC): Must run normal and abnormal QC materials daily (or with each batch) to verify accuracy and precision.
Data Management: Stores patient results, QC data, and calibration curves. Often includes connectivity (USB, RS-232) for data transfer to a LIS.

3. PHYSICAL & OPERATIONAL PROPERTIES

Form Factor: Compact benchtop unit with a user interface (touchscreen or keypad) and a built-in thermal printer.
Reagents & Consumables: Uses specific, often proprietary, reagent kits (thromboplastin, aPTT reagent, calcium chloride, etc.) and disposable cuvettes or tips.
Operation Modes: May offer fully automatic (pipetting, incubation, measurement, cleaning) or semi-automatic (manual reagent addition) modes to suit different laboratory workflows and skill levels.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Approvals: Must carry CE Marking (for EU market) and other regional medical device approvals. FDA 510(k) clearance is required for sale in the USA.
Standardization: PT/INR results must be traceable to the World Health Organization (WHO) International Reference Preparations.
Quality Standards: Manufactured under ISO 13485.
Safety: Complies with IEC 61010-1 for laboratory equipment safety. Includes protections for electrical and biohazard safety.

5. STORAGE & HANDLING ATTRIBUTES

Analyzer Storage: Operate and store in a stable, clean laboratory environment (15-30°C). Protect from vibration and direct sunlight.
Reagent Storage: Most liquid reagents require storage at 2-8°C. Reconstituted reagents and some working solutions have limited stability at 2-8°C or room temperature. Must adhere strictly to expiration dates.
Sample Handling: Citrated plasma samples must be processed (centrifuged) within a specified time (usually 4 hours) and tested promptly or frozen at -20°C or below to preserve coagulation factors.
Maintenance: Requires daily cleaning of probes and cuvette holders, weekly or monthly maintenance (e.g., cleaning optical systems, checking pipetting volumes), as per the operator's manual.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: The essential instrument for performing routine and specialized coagulation testing in clinical laboratories, anticoagulation clinics, and hospital settings.
Critical Value Reporting: Results like extremely high INR or prolonged aPTT are often critical values that require immediate notification to the treating physician.

SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

Biohazard: All patient samples and used cuvettes/tips are potentially infectious. Wear appropriate PPE (gloves, lab coat, safety glasses). Decontaminate work surfaces regularly.
Reagent Hazards: Some reagents may contain hazardous materials (e.g., sodium azide as a preservative). Consult Safety Data Sheets (SDS) and handle them with care.
Electrical Safety: Ensure proper grounding. Do not use it if the power cord is damaged.
Sharp Objects: Use caution with sample tubes and pipette tips to prevent needlestick injuries.

2. FIRST AID MEASURES

Sample/Reagent Contact: In case of contact with skin or eyes, rinse immediately with plenty of water for at least 15 minutes. Seek medical attention for eye exposure.
Ingestion: If reagents are ingested, seek immediate medical attention and provide the SDS.
Electrical Shock: Disconnect power. Do not touch the injured person if they are still in contact with the current. Provide first aid and call for emergency help.

3. FIRE FIGHTING MEASURES

Flammability: Internal plastics, electronics, and reagents are combustible.
Extinguishing Media: For electrical fires, use a CO₂ or dry chemical (Class C) extinguisher.
Special Procedures: Evacuate the area. Firefighters should use full protective gear and SCBA.

Coagulation Analyzer

Coagulation Analyzer

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Monitoring Anticoagulant Therapy:

How it helps: Acts as a safety guardian for patients on blood thinners, giving doctors the precise information they need to adjust doses so the medication is strong enough to prevent dangerous clots but not so strong that it causes life-threatening bleeding.

2. Diagnosis of Bleeding & Thrombotic Disorders:

Primary Use: Essential for evaluating patients with unexplained bleeding, bruising, or a history of thrombosis. It helps diagnose coagulation factor deficiencies (e.g., Hemophilia A/B via aPTT), vitamin K deficiency, liver disease, and disseminated intravascular coagulation (DIC).

How it helps: Provides answers for patients suffering from mysterious bleeding or clotting episodes, identifying the root cause so they can receive targeted treatment and understand why their body is not clotting normally.

3. Pre-operative Coagulation Screening:

Primary Use: Routinely performed before surgeries (especially major or invasive procedures) to identify patients with unsuspected coagulopathies (e.g., prolonged PT/aPTT) that could lead to excessive surgical bleeding.

How it helps: Prevents surgical disasters by catching hidden bleeding risks before the first incision, allowing the surgical team to take precautions and ensuring patients can undergo procedures safely.

4. Assessment of Liver Function:

Primary Use: The Prothrombin Time (PT) is a sensitive marker of the liver’s synthetic function, as the liver produces most coagulation factors. A prolonged PT can indicate significant liver damage or disease.

How it helps: Provides doctors with a crucial window into liver health, helping them detect liver damage early and monitor disease progression in patients with hepatitis, cirrhosis, or other liver conditions.

5. Evaluation of Coagulation Factor Activity:

Primary Use: Used to perform specific factor assays (e.g., Factor VIII, IX) to quantify the level of a deficient factor, which is critical for diagnosing and managing inherited bleeding disorders.

How it helps: Gives patients with hemophilia and their doctors precise information about which clotting factor is deficient and by how much, enabling targeted replacement therapy that can prevent bleeding episodes and joint damage.

SECONDARY & SUPPORTIVE USES

2. Detection of Lupus Anticoagulants & Antiphospholipid Syndrome: Performs specialized tests like the dilute Russell’s viper venom time (dRVVT) and lupus-sensitive aPTT as part of the diagnostic workup, helping identify an autoimmune condition that causes dangerous blood clots.

3. Point-of-Care Testing (POCT): In critical care units (ICU, Cardiac Cath Lab) or operating rooms, coagulation analyzers provide rapid results to guide immediate clinical decisions, ensuring critically ill patients receive timely interventions.

4. Research & Drug Development: Used in clinical trials for new anticoagulant and procoagulant drugs, helping researchers develop safer, more effective medications for patients with clotting disorders.

1. BASIC IDENTIFICATION ATTRIBUTES

Device Type: Automated, Benchtop Coagulation Analyzer.

Methodology: Typically uses photometric (optical density) detection to measure clot formation. Some models may also use mechanical (ball or viscosity) detection.

Test Principle: Measures the time it takes for a plasma sample to clot after the addition of specific reagents (e.g., thromboplastin for PT, activator/phospholipids for aPTT).

2. TECHNICAL & PERFORMANCE PROPERTIES

Core Tests Performed:

Prothrombin Time (PT) / International Normalized Ratio (INR)

Activated Partial Thromboplastin Time (aPTT)

Thrombin Time (TT)

Fibrinogen (Clauss Method)

D-Dimer (on some models)

Throughput & Channels: Designed for small to medium workload (e.g., 1-4 independent channels), allowing for simultaneous or sequential testing of different parameters on a single sample. Typical throughput of 50-100 tests per hour.

Sample Type: Uses citrated plasma (blood collected in 3.2% sodium citrate tubes, centrifuged to obtain platelet-poor plasma). Capable of testing single samples or small batches.

Calibration & ISI: Requires calibration with International Sensitivity Index (ISI)-specific calibrators for PT/INR to ensure standardized, reproducible results across instruments and laboratories.

Quality Control (QC): Must run normal and abnormal QC materials daily (or with each batch) to verify accuracy and precision.

Data Management: Stores patient results, QC data, and calibration curves. Often includes connectivity (USB, RS-232) for data transfer to a LIS.

3. PHYSICAL & OPERATIONAL PROPERTIES

Form Factor: Compact benchtop unit with a user interface (touchscreen or keypad) and a built-in thermal printer.

Reagents & Consumables: Uses specific, often proprietary, reagent kits (thromboplastin, aPTT reagent, calcium chloride, etc.) and disposable cuvettes or tips.

Operation Modes: May offer fully automatic (pipetting, incubation, measurement, cleaning) or semi-automatic (manual reagent addition) modes to suit different laboratory workflows and skill levels.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Approvals: Must carry CE Marking (for EU market) and other regional medical device approvals. FDA 510(k) clearance is required for sale in the USA.

Standardization: PT/INR results must be traceable to the World Health Organization (WHO) International Reference Preparations.

Quality Standards: Manufactured under ISO 13485.

Safety: Complies with IEC 61010-1 for laboratory equipment safety. Includes protections for electrical and biohazard safety.

5. STORAGE & HANDLING ATTRIBUTES

Analyzer Storage: Operate and store in a stable, clean laboratory environment (15-30°C). Protect from vibration and direct sunlight.

Reagent Storage: Most liquid reagents require storage at 2-8°C. Reconstituted reagents and some working solutions have limited stability at 2-8°C or room temperature. Must adhere strictly to expiration dates.

Sample Handling: Citrated plasma samples must be processed (centrifuged) within a specified time (usually 4 hours) and tested promptly or frozen at -20°C or below to preserve coagulation factors.

Maintenance: Requires daily cleaning of probes and cuvette holders, weekly or monthly maintenance (e.g., cleaning optical systems, checking pipetting volumes), as per the operator's manual.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: The essential instrument for performing routine and specialized coagulation testing in clinical laboratories, anticoagulation clinics, and hospital settings.

Critical Value Reporting: Results like extremely high INR or prolonged aPTT are often critical values that require immediate notification to the treating physician.

1. SAFETY PRECAUTIONS

Biohazard: All patient samples and used cuvettes/tips are potentially infectious. Wear appropriate PPE (gloves, lab coat, safety glasses). Decontaminate work surfaces regularly.

Reagent Hazards: Some reagents may contain hazardous materials (e.g., sodium azide as a preservative). Consult Safety Data Sheets (SDS) and handle them with care.

Electrical Safety: Ensure proper grounding. Do not use it if the power cord is damaged.

Sharp Objects: Use caution with sample tubes and pipette tips to prevent needlestick injuries.

2. FIRST AID MEASURES

Sample/Reagent Contact: In case of contact with skin or eyes, rinse immediately with plenty of water for at least 15 minutes. Seek medical attention for eye exposure.

Ingestion: If reagents are ingested, seek immediate medical attention and provide the SDS.

Electrical Shock: Disconnect power. Do not touch the injured person if they are still in contact with the current. Provide first aid and call for emergency help.

3. FIRE FIGHTING MEASURES

Flammability: Internal plastics, electronics, and reagents are combustible.

Extinguishing Media: For electrical fires, use a CO₂ or dry chemical (Class C) extinguisher.

Special Procedures: Evacuate the area. Firefighters should use full protective gear and SCBA.

Related products

BRANDS

FOLLOW US